Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone geometry and skeletal fragility.

Mary L Bouxsein1, David Karasik

  • 1Orthopedic Biomechanics Laboratory, RN115, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA. mbouxsei@bidmc.harvard.edu

Current Osteoporosis Reports
|July 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk.

Communications medicine·2026
Same author

Genome-wide Association Studies of over 30,000 Samples with Bone Mineral Density at Multiple Skeletal Sites and Its Clinical Relevance.

Genomics, proteomics & bioinformatics·2025
Same author

Picolinic acid, a tryptophan metabolite, exhibits anabolic effects in muscle cells and improves lifespan and movement in C. elegans.

The journals of gerontology. Series A, Biological sciences and medical sciences·2025
Same author

Membrane Palmitoylated Protein 7 is Required for Osteogenesis and is Linked with Bone Mineralization and Osteoporosis: The Functional Evaluation of GEFOS GWAS Hit.

Calcified tissue international·2025
Same author

Determining population-specific risk factors for COVID-19 susceptibility and severity to inform future individual-level integrated risk scoring.

BMC infectious diseases·2025
Same author

Multi-ancestry whole genome sequencing analysis of lean body mass.

Genome biology·2025
Same journal

Beyond Fracture Probability: Communicating the Full Consequences of Fracture and Contextualization.

Current osteoporosis reports·2026
Same journal

Time-Lapse HR-pQCT: an in Vivo Imaging-Based Assessment of Bone Remodeling Dynamics.

Current osteoporosis reports·2026
Same journal

Cone Beam Computed Tomography of Bonejaws in Patients With Primary Osteoporosis: A Systematic Review.

Current osteoporosis reports·2026
Same journal

Testosterone and Bone Health in Men.

Current osteoporosis reports·2026
Same journal

Stimulant Medications and Bone Health.

Current osteoporosis reports·2026
Same journal

The Innate and Adaptive Immune Functions of Osteoblast-Lineage Cells.

Current osteoporosis reports·2026
See all related articles

Bone geometry, including size and shape, significantly impacts skeletal fragility and fracture risk beyond bone mineral density. Further research using 3D imaging is needed to fully understand its clinical utility in osteoporosis.

Area of Science:

  • Orthopedics and Biomechanics
  • Osteoporosis Research
  • Skeletal Fragility

Background:

  • Bone mineral density (BMD) is a primary fracture risk factor, but its predictive limitations are increasingly recognized.
  • Skeletal fragility is influenced by factors beyond BMD, such as bone size, shape, and microarchitecture.
  • Assessing fracture risk and treatment response requires a comprehensive understanding of skeletal health.

Purpose of the Study:

  • To review the relationship between bone geometry and skeletal fragility.
  • To examine the impact of bone geometry on bone strength and fracture risk.
  • To discuss the effects of osteoporosis therapies on femoral geometry.

Main Methods:

  • Review of clinical studies and recent data on bone geometry and fracture risk.

Related Experiment Videos

  • Analysis of the influence of bone size and shape on biomechanical strength.
  • Examination of data on osteoporosis therapies and their effects on femoral geometry.

    • Main Results:

    • Bone geometry (size, shape) significantly influences biomechanical strength and skeletal fragility.
    • There is no consensus on specific geometric parameters for improved fracture risk prediction.
    • Antiresorptive and anticatabolic therapies may alter femoral geometry, but this requires further validation.
    • Current 2D techniques limit the assessment of bone geometry; 3D imaging is needed.

    Conclusions:

    • Bone geometry is a critical determinant of skeletal fragility, complementing BMD measurements.
    • Further research, particularly using 3D imaging, is essential to define optimal geometric parameters for fracture risk assessment.
    • Understanding the impact of therapies on bone geometry will enhance clinical management of osteoporosis.